• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Eitan Medical appoints new CFO

July 18, 2023 By Sean Whooley

Shaul Sharoni LinkedIn CFO Eitan Medical
Shaul Sharoni. [Image from LinkedIn]
Drug delivery technology developer Eitan Medical announced today that it appointed Shaul Sharoni as its new chief financial officer.

Sharoni brings more than 20 years of experience in financial management to the Netanya, Israel-based company. As CFO, his duties include overseeing all financial operations. That includes strategic financial planning, budgeting, forecasting and financial reporting.

According to a news release, Sharoni’s position plays a crucial role in managing investor relations and driving growth. He’s also responsible for ensuring the long-term success of the company in a dynamic healthcare industry.

“We are thrilled to welcome Shaul Sharoni to the Eitan Medical team,” said Shaul Eitan, CEO of Eitan Medical. “His extensive financial background and deep understanding of the medtech and digital health sectors will be invaluable as we scale our business, continue to expand our global presence and develop innovative solutions that improve patient care.”

Before joining Eitan Medical, Sharoni held a number of CFO positions across private and public organizations. His experience spans both the medical device and digital health industries.

Sharoni led a successful initial public offering at Itamar Medical and brings a proven track record of implementing effective financial strategies. The company said his specialties also include driving growth and profitability, making him “an ideal fit” for the company.

“I am honored to join Eitan Medical at such an exciting time in the company’s journey,” said Sharoni. “Eitan Medical has established itself as a leader in infusion therapy, and I look forward to contributing to its continued success by driving financial excellence and supporting its strategic objectives.”

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Personnel Tagged With: Eitan Medical, Personnel Moves

IN CASE YOU MISSED IT

  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7
  • Tandem, Abbott strike deal to pair insulin pumps with glucose-ketone monitor

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS